An Update on Autophagy in Prion Diseases

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Autophagy is a crucial cellular process for degrading damaged proteins and organelles.
• Defects in autophagy are linked to neurodegenerative diseases, including prion diseases (transmissible spongiform encephalopathies - TSEs).
• Prion diseases involve the accumulation of misfolded prion proteins (PrPSc) in the central nervous system.

Purpose of the Study:

• To review the current understanding of autophagy's role in prion diseases.
• To explore whether autophagy is beneficial or detrimental in prion neuropathology.
• To discuss the potential of modulating autophagy as a therapeutic strategy for TSEs.

Main Methods:

• Review of morphological, genetic, and biochemical studies on autophagy in TSE models.
• Analysis of the interaction between cellular prion protein (PrPc) and the autophagic pathway.
• Examination of autophagic activity in in vitro and in vivo TSE models and human cases.

Main Results:

• Abnormal autophagic activity is frequently observed in various TSE models and human prion diseases.
• Autophagy appears to be implicated in prion neuropathology, with impaired function potentially contributing to disease pathogenesis.
• Autophagy acts as a host defense mechanism, aiding in the clearance of aggregated prion proteins.

Conclusions:

• Autophagy plays a complex role in prion diseases, with evidence suggesting both involvement in pathogenesis and a protective host defense function.
• Stimulating autophagic flux demonstrates anti-prion effects, highlighting its therapeutic potential.
• Targeting autophagy represents a promising avenue for developing novel treatments for prion diseases.